Sexual dysfunction in female patients with anal cancer treated with curative intent: A systematic review of the literature

Mejia-Gomez, Javier; Petrovic, Irina; Doherty, Mary K.; Kennedy, Erin; Wolfman, Wendy; Jacobson, Michelle; Philippopoulos, Eleni; Lukovic, Jelena

doi:10.1016/j.radonc.2022.109437

Cited by 3 publications

(1 citation statement)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Whether the addition of chemotherapy also aggravates late side effects of radiotherapy is less known. Long-term side effects on urinary and sexual function may change years after treatment [8][9][10] and it is of importance to collect patient reported data to fully understand the side-effects experienced. There is little data on urinary and sexual function in the scientific literature [11].…”

Section: Introductionmentioning

confidence: 99%

Patient reported long‐term side effects from treatment on urinary and sexual function in anal cancer survivors – 3‐ and 6‐year results from the Swedish national ANCA study

Axelsson,

Johansson,

Haglind

et al. 2024

Colorectal Disease

View full text Add to dashboard Cite

AimThe standard treatment for anal cancer is chemoradiotherapy. Most patients survive anal cancer but remain living with long‐term side effects related to the treatment received. The aim of this study was to assess the occurrence of long‐term impairment of urinary and sexual function at 3 and 6 years after diagnosis and to investigate the additive effect from chemotherapy in combined chemoradiotherapy on urinary incontinence, compared to radiotherapy alone.MethodThe ANal CAncer study (ANCA) is based on a national Swedish cohort of patients diagnosed with anal cancer between 2011 and 2013. All identified patients within the study were invited to respond to a study‐specific questionnaire at 3 and 6 years. Descriptive analyses for the primary endpoint were performed. To investigate a possible additional effect from chemotherapy logistic regression was used.ResultsA total of 388 patients were included in the study. At 3 years 264 patients were alive and invited to respond to an anal cancer specific questionnaire. The 3‐ and 6 year response rates were 195 (74%) and 155 patients (67%), respectively. The patient reported urinary function impairment at 3 years were urgency (63%), incomplete bladder emptying (47%), and incontinence (46%) and there was an absolute increase of the prevalence of urinary dysfunction in about 10% at 6 years. Three years after diagnosis, 77% reported that intercourse was not part of their sex life; this percentage increased at 6 years to 83%. We found no negative effect of chemotherapy in combined chemoradiotherapy versus radiotherapy alone on patient reported urinary incontinence.ConclusionFor anal cancer survivors, urinary function was impaired after 3 years and continued to deteriorate as measured at 6 years after diagnosis. Anal cancer and its treatment negatively affected sexual function for both men and women. This may explain why patients reported that sexual activity and frequency of intercourse was not of importance in their life.

show abstract